<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Editas Medicine, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Editas Medicine, Inc.

    As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $571,000,000
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Cynthia Collins
    • FOUNDED
      2013
    • EMPLOYEES
      101-250
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    OptiNose, Inc.

    OptiNose, Inc.

    Optinose is a specialty pharmaceutical company focused on creating and bringing to...

    Optinose is a specialty pharmaceutical company ...

    Filing Type:    PU
    Obalon Therapeutics, Inc.

    Obalon Therapeutics, Inc.

    Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based, vertically integrate...

    Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a Sa...

    Filing Type:    PU
    Osmotica Pharmaceuticals plc

    Osmotica Pharmaceuticals plc

    Osmotica Pharmaceuticals plc is a fully-integrated biopharmaceutical company focus...

    Osmotica Pharmaceuticals plc is a fully-integra...

    Filing Type:    PU
    Repligen Corporation

    Repligen Corporation

    Repligen Corporation is a global bioprocessing company that develops and commercia...

    Repligen Corporation is a global bioprocessing ...

    Filing Type:    PU
    ICU Medical, Inc.

    ICU Medical, Inc.

    ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medica...

    ICU Medical, Inc. (Nasdaq:ICUI) develops, manuf...

    Filing Type:    PU
    IRIDEX Corporation

    IRIDEX Corporation

    IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, ma...

    IRIDEX Corporation was founded in 1989 and is a...

    Filing Type:    PU
    Precision BioSciences, Inc.

    Precision BioSciences, Inc.

    Precision BioSciences is dedicated to improving life (DTIL) through its proprietar...

    Precision BioSciences is dedicated to improving...

    Filing Type:    PU
    Sangamo Therapeutics, Inc.

    Sangamo Therapeutics, Inc.

    Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into ...

    Sangamo Therapeutics, Inc. is focused on transl...

    Filing Type:    PU
    LogicBio Therapeutics, Inc.

    LogicBio Therapeutics, Inc.

    LogicBio is a Cambridge, MA-based genome editing company focused on delivering the...

    LogicBio is a Cambridge, MA-based genome editin...

    Filing Type:    PU
    ©2024 National Investor Network. All Rights Reserved.